Results 321 to 330 of about 221,455 (333)

Rituximab Induction Immunotherapy for First-Line Low-Tumor-Burden Follicular Lymphoma: Survival Analyses With 7-Year Follow-Up

Annals of Oncology, 2012
Eric Deconinck, Gilles Salles, Catherine Thieblemont   +2 more
exaly  

Neutrophil Role in in Vivo Anti-Lymphoma Activity of Rituximab: FCGR3B-NA1/NA2 Polymorphism Does Not Influence Response and Survival After Rituximab Treatment

Annals of Oncology, 2008
Gilles Salles, H Watier, P Colombat
exaly  

Rituximab

Reactions Weekly, 2006
openaire   +2 more sources

Primary Mediastinal B-Cell Lymphoma Treated With CHOP-Like Chemotherapy With or Without Rituximab: Results of the Mabthera International Trial Group Study

Annals of Oncology, 2011
Anders Österborg, Ruth Pettengell, Anthony Ho   +2 more
exaly  

A Phase II Trial of Lenalidomide Plus Rituximab in Previously Untreated Follicular Non-Hodgkin’s Lymphoma (NHL): CALGB 50803 (Alliance)

Annals of Oncology, 2017
Eric D. Hsi, N L Bartlett, S -H Jung
exaly  

Rituximab

Reactions Weekly, 2013
openaire   +2 more sources

CD5 Expression Is Potentially Predictive of Poor Outcome Among Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus CHOP Therapy

Annals of Oncology, 2008
Kengo Takeuchi, Yasuhito Terui, M Tanimoto   +2 more
exaly  

Efficiency of in Vivo Purging With Rituximab Prior to Autologous Peripheral Blood Progenitor Cell Transplantation in B-Cellnon-Hodgkin’s Lymphoma: A Single Institution Study

Annals of Oncology, 2004
K Belhadj, C Haioun, M -H Delfau-Larue
exaly  

Rituximab

Reactions Weekly, 2012
openaire   +1 more source

A Phase II Multicenter Trial of hyperCVAD MTX/Ara-C and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma; SWOG 0213

Annals of Oncology, 2013
Joseph M Unger, T P Miller, E Epner
exaly